Physician profile
Christopher Warren Johnson
NPI 1770562712
$18,700.44
in general payments reported to CMS, 2019-2025
47 companies · $4,374 in 2025
The $4,374 reported for 2025 was more than what 90% of Urology providers received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,288 · 2020: $2,784 · 2021: $1,536 · 2022: $2,513 · 2023: $2,522 · 2024: $2,684 · 2025: $4,374.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $8,169 · Consulting Fee: $1,336 · Education: $54.99 · Travel and Lodging: $20.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $8,169.01 |
| Consulting Fee | $1,336.00 |
| Education | $54.99 |
| Travel and Lodging | $20.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $2,173.07 | 2019-2025 | |
| Ferring Pharmaceuticals INC. | $1,572.34 | 2019-2025 | Adstiladrin |
| Sumitomo Pharma America, INC. | $1,272.29 | 2023-2025 | Gemtesa, Orgovyx |
| Neotract INC. | $1,223.72 | 2019-2020 | |
| Dendreon Pharmaceuticals LLC | $1,158.05 | 2019-2025 | Provenge |
| Janssen Biotech, INC. | $1,035.51 | 2020-2025 | Erleada, Carvykti, Rybrevant |
| Astellas Pharma US INC | $993.32 | 2019-2025 | Xtandi |
| Teleflex LLC | $858.69 | 2021-2025 | Urolift, Barrigel |
| Pfizer INC. | $788.42 | 2019-2025 | |
| Abbvie INC. | $717.22 | 2019-2025 | |
| Astrazeneca Pharmaceuticals LP | $639.55 | 2022-2025 | Lynparza |
| Sun Pharmaceutical Industries INC. | $586.67 | 2020-2025 | Yonsa |
| Coloplast Corp | $478.94 | 2019-2025 | Titan |
| Urogen Pharma, INC. | $464.73 | 2021-2025 | |
| Boston Scientific Corporation | $397.94 | 2019-2023 | Spaceoar Vue System - 10ml, Lithovue |
Show all 47 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Myriad Genetic Laboratories, INC. | $335.07 | 2020-2024 | Myrisk, Prolaris |
| Endo Pharmaceuticals INC. | $332.65 | 2019-2024 | Xiaflex |
| Urovant Sciences INC | $325.01 | 2022 | |
| Blue Earth Diagnostics | $295.73 | 2021-2024 | |
| Procept Biorobotics Corporation | $274.27 | 2023-2025 | Aquabeam Robotic System |
| Tolmar Pharmaceuticals, INC. | $248.18 | 2019-2022 | |
| Bluewind Medical | $214.56 | 2024-2025 | Revi |
| Accord Healthcare, INC. | $209.68 | 2024-2025 | |
| Antares Pharma, INC. | $198.05 | 2023-2025 | Xyosted, Nocdurna, Tlando |
| Immunitybio, INC. | $179.61 | 2025 | |
| Sanara Medtech INC. | $155.71 | 2021 | |
| Verity Pharmaceuticals INC. | $147.87 | 2022-2025 | Trelstar, Tlando |
| Myovant Sciences INC. | $142.52 | 2021-2022 | |
| Amgen INC. | $140.93 | 2019-2021 | |
| Progenics Pharmaceuticals, INC. | $127.42 | 2021-2025 | |
| Endo USA, INC. | $115.82 | 2024-2025 | Xiaflex, Aveed |
| Merck Sharp & Dohme LLC | $110.40 | 2020-2025 | Lynparza, Keytruda |
| Olympus America INC. | $100.29 | 2022-2024 | Itind System |
| Palette Life Sciences, INC. | $91.57 | 2022 | |
| Caris Mpi, INC. | $90.72 | 2025 | Mi Cancer Seek |
| Allergan, INC. | $78.66 | 2020-2022 | |
| Axonics, INC. | $61.74 | 2022 | |
| Foundation Medicine, INC. | $55.45 | 2020-2023 | Foundationone Liquid Cdx |
| Seagen INC. | $54.99 | 2025 | |
| Photocure INC | $54.88 | 2019 | |
| Clovis Oncology, INC. | $43.52 | 2020 | |
| Pacira Pharmaceuticals Incorporated | $31.87 | 2022 | |
| Therapeuticsmd, INC. | $31.72 | 2019 | |
| Tolmar, INC. | $27.83 | 2023 | |
| Philips North America LLC | $21.99 | 2022 | |
| Intuitive Surgical, INC. | $21.72 | 2019 | |
| Metuchen Pharmaceuticals | $19.55 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Johnson listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.